INCENTIVE results that are public will be made available here and at the INCENTIVE Zenodo community (https://zenodo.org/communities/incentive/).
Publications
- Naoko Uno, Thomas Ebensen, Carlos A Guzman, Ted M Ross. Intranasal administration of octavalent next-generation influenza vaccine elicits protective immune responses against seasonal and pre-pandemic viruses. J Virol. 2024 Sep 17;98(9):e0035424. doi: 10.1128/jvi.00354-24.
- Naoko Uno, Ted M Ross. Multivalent next generation influenza virus vaccines protect against seasonal and pre-pandemic viruses.
Sci Rep. 2024 Jan 16;14(1):1440. doi: 10.1038/s41598-023-51024-0. - Carlos A Guzman. Next Generation Influenza Vaccines: Looking into the Crystal Ball. Vaccines (Basel). 2020 Aug 21;8(3):464. doi: 10.3390/vaccines8030464.
Deliverables (public)
-
D1.2:Communication Plan, PowerPoint presentation of the INCENTIVE project and PowerPoint presentation of the INCENTIVE project websitepdf (9.12 MB)
-
D4.2 INCENTIVE-QIV:Registration of the clinical trial in the trial registry.pdf (9.85 MB)
-
D4.6 INCENTIVE-QIV-1,2,3 (EU) and QIV-1 (India):Study results posted in the study registrypdf (0.68 MB)
